Hypoxia and Intestinal Inflammation: Common Molecular Mechanisms and Signaling Pathways
暂无分享,去创建一个
[1] A. Piotrowska,et al. Etiology of IBD—Is It Still a Mystery? , 2022, International journal of molecular sciences.
[2] C. Taylor,et al. Hypoxia-inducible factor (HIF) as a bridge between healthy barrier function, wound healing, and fibrosis. , 2022, American journal of physiology. Cell physiology.
[3] A. Bäumler,et al. The microbiome and gut homeostasis , 2022, Science.
[4] Sen Li,et al. Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease , 2022, Chinese Medicine.
[5] K. Allin,et al. Multiomics to elucidate inflammatory bowel disease risk factors and pathways , 2022, Nature Reviews Gastroenterology & Hepatology.
[6] R. Wenger,et al. The asparagine hydroxylase FIH - a unique oxygen sensor. , 2022, Antioxidants & redox signaling.
[7] Shuo Liang,et al. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer , 2021, Journal of Experimental & Clinical Cancer Research.
[8] B. Bošnjak,et al. Imaging dendritic cell functions * , 2021, Immunological reviews.
[9] D. McKernan. Toll-Like Receptors as Drug Targets in the Intestinal Epithelium. , 2021, Handbook of experimental pharmacology.
[10] Yan Zhu,et al. Antimicrobial Peptides: An Update on Classifications and Databases , 2021, International journal of molecular sciences.
[11] Hua Yang,et al. The role of hypoxia‐inducible factor 1‐alpha in inflammatory bowel disease , 2021, Cell biology international.
[12] I. Baranowska-Bosiacka,et al. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms , 2021, International journal of molecular sciences.
[13] Martin Wah,et al. Inflammatory bowel disease: The role of commensal microbiome in immune regulation , 2021, Gastroenterologia y hepatologia.
[14] M. Veldhoen,et al. Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site , 2021, International journal of molecular sciences.
[15] Yitao Wang,et al. HIF-1: structure, biology and natural modulators. , 2021, Chinese journal of natural medicines.
[16] Hai Hu,et al. The Roles of 2-Hydroxyglutarate , 2021, Frontiers in Cell and Developmental Biology.
[17] Zhi-yun Chen,et al. The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease , 2020, Journal of immunology research.
[18] J. Fandrey,et al. The Importance of Hypoxia-Inducible Factors (HIF-1 and HIF-2) for the Pathophysiology of Inflammatory Bowel Disease , 2020, International journal of molecular sciences.
[19] A. Bergthaler,et al. Systemic Immunometabolism: Challenges and Opportunities , 2020, Immunity.
[20] Hua Yang,et al. SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α , 2020, Journal of Molecular Medicine.
[21] Y. Shah,et al. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine , 2020, The Journal of Biological Chemistry.
[22] S. Rocha,et al. HIF-1β Positively Regulates NF-κB Activity via Direct Control of TRAF6 , 2020, International journal of molecular sciences.
[23] H. Fan,et al. Cronobacter sakazakii induces necrotizing enterocolitis by regulating NLRP3 inflammasome expression via TLR4. , 2020, Journal of medical microbiology.
[24] K. Fitzgerald,et al. Toll-like Receptors and the Control of Immunity , 2020, Cell.
[25] Ahmad Esmaillzadeh,et al. A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial , 2020, Trials.
[26] C. Taylor,et al. Hypoxia and Innate Immunity: Keeping Up with the HIFsters. , 2020, Annual review of immunology.
[27] H. Jasper. Intestinal Stem Cell Aging: Origins and Interventions. , 2020, Annual review of physiology.
[28] F. Carbone,et al. Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation , 2020, Frontiers in Immunology.
[29] H. Vlamakis,et al. Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. , 2019, Inflammatory bowel diseases.
[30] E. Sanders,et al. Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life , 2019, Nature Communications.
[31] K. Murphy,et al. Shared Transcriptional Control of Innate Lymphoid Cell and Dendritic Cell Development. , 2019, Annual review of cell and developmental biology.
[32] P. Gibson,et al. Intestinal gases: influence on gut disorders and the role of dietary manipulations , 2019, Nature Reviews Gastroenterology & Hepatology.
[33] K. Garey,et al. Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways , 2019, mBio.
[34] C. Germer,et al. Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease. , 2019, The Journal of clinical investigation.
[35] C. Taylor,et al. Hypoxia-inducible factor (HIF) hydroxylase inhibition enhances the protective effects of cyclosporine in colitis. , 2019, American journal of physiology. Gastrointestinal and liver physiology.
[36] Hua Yang,et al. Intestinal Epithelial Cells-Derived Hypoxia-Inducible Factor-1α Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes , 2019, Front. Immunol..
[37] Hu Zhang,et al. NLRP3 Inflammasome and Inflammatory Bowel Disease , 2019, Front. Immunol..
[38] Jeff F Dunn,et al. Partial pressure of oxygen in the human body: a general review. , 2019, American journal of blood research.
[39] S. Walmsley,et al. Inflammation and Hypoxia: HIF and PHD Isoform Selectivity. , 2019, Trends in molecular medicine.
[40] R. Ardy,et al. Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms , 2018, Immunological reviews.
[41] Nupur K. Das,et al. Hepatic hepcidin/intestinal HIF-2&agr; axis maintains iron absorption during iron deficiency and overload , 2018, The Journal of clinical investigation.
[42] D. Philpott,et al. NOD1 and NOD2 in inflammation, immunity and disease. , 2019, Archives of biochemistry and biophysics.
[43] J. Doré,et al. Mucosal healing and bacterial composition in response to enteral nutrition versus steroid based induction therapy - a randomized prospective clinical trial in children with Crohn's disease. , 2018, Journal of Crohn's & colitis.
[44] Zhihui Feng,et al. Modulation of HIF-2α PAS-B domain contributes to physiological responses , 2018, Proceedings of the National Academy of Sciences.
[45] A. Petersen,et al. Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease , 2018, Front. Med..
[46] W. Strober,et al. The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease , 2018, Front. Immunol..
[47] F. Gonzalez,et al. The role of hypoxia-inducible factors in metabolic diseases , 2018, Nature Reviews Endocrinology.
[48] J. Allaire,et al. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity. , 2018, Trends in immunology.
[49] L. Lartigue,et al. Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells , 2018, Cells.
[50] Yajin Zhao,et al. Nitric oxide in red blood cell adaptation to hypoxia , 2018, Acta biochimica et biophysica Sinica.
[51] C. Stockmann,et al. Hypoxia, Metabolism and Immune Cell Function , 2018, Biomedicines.
[52] Katsuaki Sato,et al. The HDAC Inhibitor, SAHA, Prevents Colonic Inflammation by Suppressing Pro-inflammatory Cytokines and Chemokines in DSS-induced Colitis , 2018, Acta histochemica et cytochemica.
[53] C. Elly,et al. E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin‐33 Receptor , 2018, Immunity.
[54] Andrew J. Oler,et al. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease , 2018, The Journal of clinical investigation.
[55] L. Van Kaer,et al. Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier. , 2017, Trends in immunology.
[56] C. Taylor,et al. Hypoxia‐sensitive pathways in intestinal inflammation , 2017, The Journal of physiology.
[57] A. Harris,et al. Advances in Hypoxia-Inducible Factor Biology. , 2017, Cell metabolism.
[58] C. Taylor. Hypoxia in the Gut , 2017, Cellular and molecular gastroenterology and hepatology.
[59] J. Danesh,et al. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease , 2017, Mucosal Immunology.
[60] G. Schett,et al. Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease , 2018, Nature Communications.
[61] M. Veldhoen,et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases , 2018, Nature Communications.
[62] J. Fandrey,et al. Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis , 2017, PloS one.
[63] W. D. de Vos,et al. C4B gene influences intestinal microbiota through complement activation in patients with paediatric‐onset inflammatory bowel disease , 2017, Clinical and experimental immunology.
[64] Y. Shoenfeld,et al. Adverse effects of gluten ingestion and advantages of gluten withdrawal in nonceliac autoimmune disease , 2017, Nutrition reviews.
[65] J. Bergh,et al. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017, Cancer cell.
[66] Yuehua Wu,et al. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis , 2017, Nature Medicine.
[67] P. Carmeliet,et al. Opposing regulation and roles for PHD3 in lung dendritic cells and alveolar macrophages , 2017, Journal of leukocyte biology.
[68] R. Wenger,et al. Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation , 2017, Nature Communications.
[69] P. Maxwell,et al. Hypoxia and B cells. , 2017, Experimental cell research.
[70] J. Raes,et al. The resilience of the intestinal microbiota influences health and disease , 2017, Nature Reviews Microbiology.
[71] L. Figueiredo. Faculty Opinions recommendation of HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. , 2017 .
[72] Xiuli Liu,et al. IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease , 2017, Gastroenterology research.
[73] Fabian Rivera-Chávez,et al. Oxygen as a driver of gut dysbiosis. , 2017, Free radical biology & medicine.
[74] G. Zhou,et al. Hypoxia inducible factor‐1α‐induced interleukin‐33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease , 2017, Clinical and experimental immunology.
[75] P. Carmeliet,et al. Haematopoietic prolyl hydroxylase‐1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis , 2017, The Journal of pathology.
[76] J. Turner,et al. The intestinal epithelial barrier: a therapeutic target? , 2017, Nature Reviews Gastroenterology &Hepatology.
[77] Inkyung Jung,et al. Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils , 2016, Molecular and Cellular Biology.
[78] E. Cummins,et al. Hypoxia-dependent regulation of inflammatory pathways in immune cells. , 2016, The Journal of clinical investigation.
[79] L. O’Neill,et al. HIF1α and metabolic reprogramming in inflammation. , 2016, The Journal of clinical investigation.
[80] Ariel L. Raybuck,et al. Germinal Center hypoxia and regulation of antibody qualities by a hypoxia response system , 2016, Nature.
[81] E. Campbell,et al. Hypoxia and Mucosal Inflammation. , 2016, Annual review of pathology.
[82] S. Ramakrishnan,et al. Role of Intestinal HIF-2α in Health and Disease. , 2016, Annual review of physiology.
[83] P. Ratcliffe,et al. Pharmacological targeting of the HIF hydroxylases--A new field in medicine development. , 2016, Molecular aspects of medicine.
[84] R. Deberardinis,et al. TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions. , 2016, Molecular cell.
[85] E. Mills,et al. Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal , 2016, European journal of immunology.
[86] J. Fandrey,et al. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis , 2015, Mucosal Immunology.
[87] M. Ohh,et al. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL). , 2016, Methods in molecular biology.
[88] Jianquan Hou,et al. Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury. , 2016, Journal of the American Society of Nephrology : JASN.
[89] E. Cummins,et al. Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[90] David K. Finlay,et al. Immunometabolism: Cellular Metabolism Turns Immune Regulator* , 2015, The Journal of Biological Chemistry.
[91] C. Germer,et al. Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[92] M. Moser,et al. Cutting Edge: Hypoxia-Inducible Factor 1 Negatively Regulates Th1 Function , 2015, The Journal of Immunology.
[93] Z. Ling,et al. PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function* , 2015, The Journal of Biological Chemistry.
[94] C. Elly,et al. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity. , 2015, Immunity.
[95] E. Campbell,et al. HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity , 2015, Molecular biology of the cell.
[96] 이지호,et al. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity. , 2015 .
[97] M. Johansson,et al. New developments in goblet cell mucus secretion and function , 2015, Mucosal Immunology.
[98] E. Campbell,et al. Stabilization of HIF through inhibition of Cullin‐2 neddylation is protective in mucosal inflammatory responses , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] Susan R. Quinn,et al. Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. , 2015, Cell metabolism.
[100] Dong-Hoon Shin,et al. HIF-1α–Mediated Upregulation of TASK-2 K+ Channels Augments Ca2+ Signaling in Mouse B Cells under Hypoxia , 2014, The Journal of Immunology.
[101] Sjoerd Post,et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.
[102] T. Mach,et al. Clostridium difficile infection in patients with inflammatory bowel disease , 2014, Przeglad gastroenterologiczny.
[103] S. Ramakrishnan,et al. Hypoxia-Inducible Factor/MAZ-Dependent Induction of Caveolin-1 Regulates Colon Permeability through Suppression of Occludin, Leading to Hypoxia-Induced Inflammation , 2014, Molecular and Cellular Biology.
[104] C. Taniguchi,et al. PHD Inhibition Mitigates and Protects Against Radiation-Induced Gastrointestinal Toxicity via HIF2 , 2014, Science Translational Medicine.
[105] Se Jin Song,et al. The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.
[106] V. Chauthaiwale,et al. Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis , 2014, Clinical and experimental gastroenterology.
[107] R. Nemenoff,et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.
[108] F. Formenti,et al. Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. , 2014, Blood.
[109] J. Espinosa,et al. Transcriptional regulation by hypoxia inducible factors , 2014, Critical reviews in biochemistry and molecular biology.
[110] A. Baird,et al. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis , 2013, Mucosal Immunology.
[111] D. Laukens,et al. Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn’s disease/infectious colitis and healthy controls , 2013, Journal of Inflammation.
[112] D. Finn,et al. An apPEAling new therapeutic for ulcerative colitis? , 2013, Gut.
[113] A. Cheong,et al. Regulation of IL-1β–induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways , 2013, Proceedings of the National Academy of Sciences.
[114] J. Greenson,et al. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. , 2013, Gastroenterology.
[115] P. Muranski,et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.
[116] C. Peyssonnaux,et al. The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions. , 2013, Blood.
[117] R. Sumpter,et al. Intestinal epithelial autophagy is essential for host defense against invasive bacteria. , 2013, Cell host & microbe.
[118] J. Fandrey,et al. Role of hypoxia inducible factor-1α for interferon synthesis in mouse dendritic cells , 2013, Biological chemistry.
[119] Liang Zheng,et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.
[120] W. Michalski,et al. TLR4, IL10RA, and NOD2 mutation in paediatric Crohn’s disease patients: an association with Mycobacterium avium subspecies paratuberculosis and TLR4 and IL10RA expression , 2013, Medical Microbiology and Immunology.
[121] D. Pardoll,et al. Metabolic control of the Treg/Th17 axis , 2013, Immunological reviews.
[122] Rui Chen,et al. Allosteric Inhibition of Hypoxia Inducible Factor-2 with Small Molecules , 2013, Nature chemical biology.
[123] E. Cummins,et al. The Hydroxylase Inhibitor Dimethyloxallyl Glycine Attenuates Endotoxic Shock Via Alternative Activation of Macrophages and IL-10 Production by B1 Cells , 2011, Shock.
[124] Tomohiro Watanabe,et al. NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.
[125] P. Carmeliet,et al. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. , 2011, The Journal of clinical investigation.
[126] P. Carmeliet,et al. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. , 2010, Gastroenterology.
[127] N. Reiner. Macrophages and Dendritic Cells , 2009, Methods in Molecular Biology™.
[128] S. Colgan,et al. Selective induction of mucin‐3 by hypoxia in intestinal epithelia , 2006, Journal of cellular biochemistry.
[129] P. Gibson,et al. Microscopic colitis , 2002, Journal of Gastroenterology and Hepatology.
[130] I. Leodolter. [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.